Summary:
- This article discusses an experimental therapy that could potentially act as a "universal antiviral" against a wide range of viruses, including influenza, Ebola, and COVID-19.
- The therapy works by targeting a specific human protein that many viruses rely on to infect and replicate within human cells, rather than targeting the viruses themselves.
- This approach could lead to the development of a broad-spectrum antiviral drug that could be effective against both known and emerging viral threats, providing a valuable tool in the fight against infectious diseases.